TAILIEUCHUNG - Rifabutin for treating pulmonary tuberculosis (Review)

Among current challenges in tuberculosis treatment are reducing the length of time that drugs must be taken to less than six months and finding ways to safely combine tuberculosis drugs with those used in the treatment of HIV infection. Rifabutin is a drug that has the potential to address these issues if substituted for rifampicin, a mainstay of current treatment. This review identified five trials involving 924 people, but none were of high quality. The review found no significant differences between rifabutin- and rifampicincontaining treatment in curing tuberculosis and preventing relapse, but higher doses of rifabutin might be associated with more adverse effects and there. | Rifabutin for treating pulmonary tuberculosis Review Davies GR Cerri S Richeldi L THE COCHRANE COLLABORATION This is a reprint of a Cochrane review prepared and maintained byThe Cochrane Collaboration and published in The Cochrane Library 2010 Issue 1 http WILEY J Publishers Since 1807 Rifabutin fortreating pulmonary tuberculosis Review Copyright 2010 The Cochrane Collaboration. Published by John Wiley Sons Ltd. TABLE OF CONTENTS HEADER . 1 ABSTRACT . 1 PLAIN LANGUAGE SUMMARY. 2 BACKGROUND. 2 OBJECTIVES . 3 METHODS. 3 RESULTS. 5 DISCUSSION. 7 AUTHORS CONCLUSIONS . 7 ACKNOWLEDGEMENTS . 8 REFERENCES. 8 CHARACTERISTICS OF STUDIES. 9 DATA AND ANALYSES. 14 Analysis . Comparison 1 Rifabutin vs rifampicin Outcome 1 Cure. 15 Analysis . Comparison 1 Rifabutin vs rifampicin Outcome 2 Relapse. 16 Analysis . Comparison 1 Rifabutin vs rifampicin Outcome 3 M. tuberculosis culture status 2 months after starting therapy. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16 Analysis . Comparison 1 Rifabutin vs rifampicin Outcome 4 M. tuberculosis culture status 3 months after starting therapy. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17 Analysis . Comparison 1 Rifabutin vs rifampicin Outcome 5 Adverse events. . . . . . . . . . . . . . 18 APPENDICES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18 WHAT S NEW. 20 HISTORY. 20 CONTRIBUTIONS OF AUTHORS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20 DECLARATIONS OF INTEREST . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20 SOURCES OF SUPPORT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20 DIFFERENCES BETWEEN PROTOCOL AND REVIEW . . . . . . . . . . . . . . . . . . . . . 21 INDEX TERMS . 21 Rifabutin for treating pulmonary tuberculosis Review Copyright 2010 The Cochrane Collaboration. Published by John Wiley Sons Ltd. i Intervention Review Rifabutin for treating pulmonary .

TAILIEUCHUNG - Chia sẻ tài liệu không giới hạn
Địa chỉ : 444 Hoang Hoa Tham, Hanoi, Viet Nam
Website : tailieuchung.com
Email : tailieuchung20@gmail.com
Tailieuchung.com là thư viện tài liệu trực tuyến, nơi chia sẽ trao đổi hàng triệu tài liệu như luận văn đồ án, sách, giáo trình, đề thi.
Chúng tôi không chịu trách nhiệm liên quan đến các vấn đề bản quyền nội dung tài liệu được thành viên tự nguyện đăng tải lên, nếu phát hiện thấy tài liệu xấu hoặc tài liệu có bản quyền xin hãy email cho chúng tôi.
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.